+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Inflammatory Bowel Disease (IBD) Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 1227788
  • Report
  • 217 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • 4Sc Ag
  • Astrazeneca Plc
  • Cosmo Pharmaceuticals Nv
  • Johnson & Johnson
  • Novartis International Ag
  • Quest Diagnostics
  • MORE
The Inflammatory Bowel Disease (IBD) Therapeutics market worldwide is projected to grow by US$1.1 Billion, driven by a compounded growth of 2.3%. Biologic Therapies, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.3 Billion by the year 2025, Biologic Therapies will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$44.8 Million to the region's size and clout in the next 5 to 6 years. Over US$33.3 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Biologic Therapies will reach a market size of US$267.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$317.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • 4SC AG
  • Abbott Nutrition
  • AbbVie, Inc.
  • Ablynx NV
  • Active Biotech AB
  • Alfasigma S.p.A.
  • Allergan PLC
  • Allergan PLC
  • Amgen, Inc.
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Athersys, Inc.
  • Atlantic Healthcare plc
  • Avaxia Biologics, Inc.
  • Biosafe Systems, LLC
  • Boehringer Ingelheim GmbH
  • Cadila Healthcare Ltd.
  • Celgene Corporation
  • Celltrion, Inc.
  • Cipla Ltd.
  • Coherus Biosciences, Inc.
  • Cosmo Pharmaceuticals NV
  • Dr. Falk Pharma GmbH
  • EA Pharma Co., Ltd.
  • Eddingpharm
  • EPIRUS Biopharmaceuticals, Inc.
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche AG
  • Galapagos NV
  • Giaconda Ltd.
  • Google LLC
  • Immunic, Inc.
  • InDex Pharmaceuticals Holding AB
  • Infinity Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • Kissei Pharmaceutical Co., Ltd.
  • LG Sciences
  • Lupin Ltd.
  • Mochida Pharmaceutical Co., Ltd.
  • Mylan Pharmaceutical Pvt. Ltd.
  • Neovacs SA
  • Nogra Pharma Limited
  • NovaMedica LLC
  • Novartis International AG
  • Osiris Therapeutics, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • PAR Pharmaceutical Companies, Inc.
  • PendoPharm, Inc.
  • Perrigo Company PLC
  • Pfenex, Inc.
  • Pfizer, Inc.
  • Pharmascience Inc.
  • Pluristem Therapeutics, Inc.
  • Qu Biologics Inc.
  • Quest Diagnostics, Inc.
  • RedHill Biopharma Ltd.
  • Reliance Life Sciences
  • Salix Pharmaceuticals, Inc.
  • Sandoz International GmbH
  • Sanofi
  • Sequella, Inc.
  • Soligenix, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Toray Industries, Inc.
  • Torrent Pharmaceuticals Ltd.
  • UCB SA
  • Zeria Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 4Sc Ag
  • Astrazeneca Plc
  • Cosmo Pharmaceuticals Nv
  • Johnson & Johnson
  • Novartis International Ag
  • Quest Diagnostics
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Inflammatory Bowel Disease (IBD) Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Inflammatory Bowel Disease (IBD) Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Inflammatory Bowel Disease (IBD) Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Inflammatory Bowel Disease (IBD) Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Biologic Therapies (Drug Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Biologic Therapies (Drug Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Biologic Therapies (Drug Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Aminosalicylates (Drug Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Aminosalicylates (Drug Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Aminosalicylates (Drug Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Antibiotics (Drug Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Antibiotics (Drug Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Antibiotics (Drug Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Corticosteroids (Drug Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Corticosteroids (Drug Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Corticosteroids (Drug Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Immunomodulators (Drug Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Immunomodulators (Drug Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Immunomodulators (Drug Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Inflammatory Bowel Disease (IBD) Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 19: United States Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 20: Inflammatory Bowel Disease (IBD) Therapeutics Market in the United States by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 21: United States Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

CANADA

TABLE 22: Canadian Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 23: Canadian Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017

TABLE 24: Inflammatory Bowel Disease (IBD) Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

JAPAN

TABLE 25: Japanese Market for Inflammatory Bowel Disease (IBD) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 26: Inflammatory Bowel Disease (IBD) Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 27: Japanese Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

CHINA

TABLE 28: Chinese Inflammatory Bowel Disease (IBD) Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 29: Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in China in US$ Million by Drug Type: 2009-2017

TABLE 30: Chinese Inflammatory Bowel Disease (IBD) Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Inflammatory Bowel Disease (IBD) Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 31: European Inflammatory Bowel Disease (IBD) Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 32: Inflammatory Bowel Disease (IBD) Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 33: European Inflammatory Bowel Disease (IBD) Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: European Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 35: Inflammatory Bowel Disease (IBD) Therapeutics Market in Europe in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 36: European Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

FRANCE

TABLE 37: Inflammatory Bowel Disease (IBD) Therapeutics Market in France by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 38: French Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017

TABLE 39: French Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

GERMANY

TABLE 40: Inflammatory Bowel Disease (IBD) Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 41: German Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 42: German Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

ITALY

TABLE 43: Italian Inflammatory Bowel Disease (IBD) Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 44: Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Type: 2009-2017

TABLE 45: Italian Inflammatory Bowel Disease (IBD) Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 46: United Kingdom Market for Inflammatory Bowel Disease (IBD) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 47: Inflammatory Bowel Disease (IBD) Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 48: United Kingdom Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

SPAIN

TABLE 49: Spanish Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 50: Spanish Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017

TABLE 51: Inflammatory Bowel Disease (IBD) Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

RUSSIA

TABLE 52: Russian Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 53: Inflammatory Bowel Disease (IBD) Therapeutics Market in Russia by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 54: Russian Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 55: Rest of Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 56: Inflammatory Bowel Disease (IBD) Therapeutics Market in Rest of Europe in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 57: Rest of Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 58: Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 59: Inflammatory Bowel Disease (IBD) Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 60: Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 61: Inflammatory Bowel Disease (IBD) Therapeutics Market in Asia-Pacific by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017

TABLE 63: Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 64: Inflammatory Bowel Disease (IBD) Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 65: Australian Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 66: Australian Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

INDIA

TABLE 67: Indian Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 68: Indian Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Review by Drug Type in US$ Million: 2009-2017

TABLE 69: Inflammatory Bowel Disease (IBD) Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

SOUTH KOREA

TABLE 70: Inflammatory Bowel Disease (IBD) Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 71: South Korean Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 72: Inflammatory Bowel Disease (IBD) Therapeutics Market Share Distribution in South Korea by Drug Type: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 73: Rest of Asia-Pacific Market for Inflammatory Bowel Disease (IBD) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 74: Inflammatory Bowel Disease (IBD) Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 75: Rest of Asia-Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 76: Latin American Inflammatory Bowel Disease (IBD) Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 77: Inflammatory Bowel Disease (IBD) Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 78: Latin American Inflammatory Bowel Disease (IBD) Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 79: Latin American Inflammatory Bowel Disease (IBD) Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 80: Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Type: 2009-2017

TABLE 81: Latin American Inflammatory Bowel Disease (IBD) Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 82: Argentinean Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 83: Inflammatory Bowel Disease (IBD) Therapeutics Market in Argentina in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 84: Argentinean Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

BRAZIL

TABLE 85: Inflammatory Bowel Disease (IBD) Therapeutics Market in Brazil by Drug Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 86: Brazilian Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Scenario in US$ Million by Drug Type: 2009-2017

TABLE 87: Brazilian Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

MEXICO

TABLE 88: Inflammatory Bowel Disease (IBD) Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 89: Mexican Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 90: Mexican Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 91: Rest of Latin America Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 92: Inflammatory Bowel Disease (IBD) Therapeutics Market in Rest of Latin America by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 93: Rest of Latin America Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 94: The Middle East Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 95: Inflammatory Bowel Disease (IBD) Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 96: The Middle East Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 97: The Middle East Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018 to 2025

TABLE 98: The Middle East Inflammatory Bowel Disease (IBD) Therapeutics Historic Market by Drug Type in US$ Million: 2009-2017

TABLE 99: Inflammatory Bowel Disease (IBD) Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025

IRAN

TABLE 100: Iranian Market for Inflammatory Bowel Disease (IBD) Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Type for the Period 2018-2025

TABLE 101: Inflammatory Bowel Disease (IBD) Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Type for the Period 2009-2017

TABLE 102: Iranian Inflammatory Bowel Disease (IBD) Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025

ISRAEL

TABLE 103: Israeli Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Forecasts in US$ Million by Drug Type: 2018-2025

TABLE 104: Inflammatory Bowel Disease (IBD) Therapeutics Market in Israel in US$ Million by Drug Type: A Historic Review for the Period 2009-2017

TABLE 105: Israeli Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 106: Saudi Arabian Inflammatory Bowel Disease (IBD) Therapeutics Market Growth Prospects in US$ Million by Drug Type for the Period 2018-2025

TABLE 107: Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Type: 2009-2017

TABLE 108: Saudi Arabian Inflammatory Bowel Disease (IBD) Therapeutics Market by Drug Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 109: Inflammatory Bowel Disease (IBD) Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 110: United Arab Emirates Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 111: Inflammatory Bowel Disease (IBD) Therapeutics Market Share Distribution in United Arab Emirates by Drug Type: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 112: Inflammatory Bowel Disease (IBD) Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Type for the Period 2018-2025

TABLE 113: Rest of Middle East Inflammatory Bowel Disease (IBD) Therapeutics Historic Market Analysis in US$ Million by Drug Type: 2009-2017

TABLE 114: Rest of Middle East Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

AFRICA

TABLE 115: African Inflammatory Bowel Disease (IBD) Therapeutics Market Estimates and Projections in US$ Million by Drug Type: 2018 to 2025

TABLE 116: Inflammatory Bowel Disease (IBD) Therapeutics Market in Africa by Drug Type: A Historic Review in US$ Million for 2009-2017

TABLE 117: African Inflammatory Bowel Disease (IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025

IV. COMPETITION

4SC AG

ABBOTT NUTRITION

ABBVIE

ABLYNX NV

ACTIVE BIOTECH AB

ALFASIGMA S.P.A.

ALLERGAN PLC

AMGEN

ASTELLAS PHARMA

ASTRAZENECA PLC

ATHERSYS

ATLANTIC HEALTHCARE PLC

AVAXIA BIOLOGICS, INC.

BIOSAFE SYSTEMS, LLC

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

CADILA HEALTHCARE

CELGENE CORPORATION

CELLTRION, INC.

CIPLA

COHERUS BIOSCIENCES , INC.

COSMO PHARMACEUTICALS NV

DR. FALK PHARMA GMBH

EA PHARMA CO., LTD.

EPIRUS BIOPHARMACEUTICALS INC.

F. HOFFMANN-LA ROCHE AG

GALAPAGOS NV

GIACONDA LTD.

GOOGLE LLC

IMMUNIC, INC.

INDEX PHARMACEUTICALS HOLDING AB

INFINITY PHARMACEUTICALS, INC.

IONIS PHARMACEUTICALS, INC.

JANSSEN BIOTECH

JOHNSON & JOHNSON

KISSEI PHARMACEUTICAL

LG SCIENCES

LUPIN

MOCHIDA PHARMACEUTICAL

MYLAN PHARMACEUTICAL PVT.

NEOVACS SA

NOGRA PHARMA LIMITED

NOVAMEDICA LLC

NOVARTIS INTERNATIONAL AG

OSIRIS THERAPEUTICS

OTSUKA PHARMACEUTICAL

PAR PHARMACEUTICAL COMPANIES

PENDOPHARM, INC.

PERRIGO CO., PLC

PFENEX, INC.

PFIZER

PHARMASCIENCE INC.

PLURISTEM THERAPEUTICS, INC.

QU BIOLOGICS INC.

QUEST DIAGNOSTICS

REDHILL BIOPHARMA LTD.

RELIANCE LIFE SCIENCES

SALIX PHARMACEUTICALS

SANDOZ INTERNATIONAL GMBH

SANOFI

SEQUELLA, INC.

SOLIGENIX

TAKEDA PHARMACEUTICAL COMPANY LIMITED

TEVA PHARMACEUTICAL INDUSTRIES

TORAY INDUSTRIES

TORRENT PHARMACEUTICALS

UCB SA

ZERIA PHARMACEUTICAL CO., LTD.

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 4Sc Ag
  • Abbott Nutrition
  • Abbvie
  • Ablynx Nv
  • Active Biotech Ab
  • Alfasigma S.P.A.
  • Allergan Plc
  • Amgen
  • Astellas Pharma
  • Astrazeneca Plc
  • Athersys
  • Atlantic Healthcare Plc
  • Avaxia Biologics, Inc.
  • Biosafe Systems, Llc
  • Boehringer Ingelheim International GMBH
  • Cadila Healthcare
  • Celgene Corporation
  • Celltrion, Inc.
  • Cipla
  • Coherus Biosciences , Inc.
  • Cosmo Pharmaceuticals Nv
  • Dr. Falk Pharma GMBH
  • Ea Pharma Co., Ltd.
  • Epirus Biopharmaceuticals Inc.
  • F. Hoffmann-La Roche Ag
  • Galapagos Nv
  • Giaconda Ltd.
  • Google Llc
  • Immunic, Inc.
  • Index Pharmaceuticals Holding Ab
  • Infinity Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Janssen Biotech
  • Johnson & Johnson
  • Kissei Pharmaceutical
  • Lg Sciences
  • Lupin
  • Mochida Pharmaceutical
  • Mylan Pharmaceutical Pvt.
  • Neovacs Sa
  • Nogra Pharma Limited
  • Novamedica Llc
  • Novartis International Ag
  • Osiris Therapeutics
  • Otsuka Pharmaceutical
  • Par Pharmaceutical Companies
  • Pendopharm, Inc.
  • Perrigo Co., Plc
  • Pfenex, Inc.
  • Pfizer
  • Pharmascience Inc.
  • Pluristem Therapeutics, Inc.
  • Qu Biologics Inc.
  • Quest Diagnostics
  • Redhill Biopharma Ltd.
  • Reliance Life Sciences
  • Salix Pharmaceuticals
  • Sandoz International GMBH
  • Sanofi
  • Sequella, Inc.
  • Soligenix
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries
  • Toray Industries
  • Torrent Pharmaceuticals
  • Ucb Sa
  • Zeria Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll